Dotz Nano Limited

ASX:DTZ Stock Report

Market Cap: AU$41.7m

Dotz Nano Management

Management criteria checks 0/4

Dotz Nano's CEO is Sharon Malka, appointed in Mar 2023, has a tenure of 1.67 years. total yearly compensation is $556.60K, comprised of 47.1% salary and 52.9% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth A$48.47K. The average tenure of the management team and the board of directors is 1.7 years and 2.1 years respectively.

Key information

Sharon Malka

Chief executive officer

US$556.6k

Total compensation

CEO salary percentage47.1%
CEO tenure1.7yrs
CEO ownership0.1%
Management average tenure1.7yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

Here's Why We're Watching Dotz Nano's (ASX:DTZ) Cash Burn Situation

Apr 07
Here's Why We're Watching Dotz Nano's (ASX:DTZ) Cash Burn Situation

Is Dotz Nano (ASX:DTZ) In A Good Position To Invest In Growth?

Jul 25
Is Dotz Nano (ASX:DTZ) In A Good Position To Invest In Growth?

Is Dotz Nano (ASX:DTZ) In A Good Position To Deliver On Growth Plans?

Mar 07
Is Dotz Nano (ASX:DTZ) In A Good Position To Deliver On Growth Plans?

We Think Dotz Nano (ASX:DTZ) Can Afford To Drive Business Growth

Sep 13
We Think Dotz Nano (ASX:DTZ) Can Afford To Drive Business Growth

Companies Like Dotz Nano (ASX:DTZ) Are In A Position To Invest In Growth

Mar 16
Companies Like Dotz Nano (ASX:DTZ) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Sharon Malka's remuneration changed compared to Dotz Nano's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$6m

Dec 31 2023US$557kUS$262k

-US$7m

Compensation vs Market: Sharon's total compensation ($USD556.60K) is above average for companies of similar size in the Australian market ($USD298.50K).

Compensation vs Earnings: Insufficient data to compare Sharon's compensation with company performance.

CEO

Sharon Malka (52 yo)

1.7yrs

Tenure

US$556,598

Compensation

Mr. Sharon Malka, C.P.A., MBA, serves as Independent External Director at BioLight Life Sciences Ltd. since March 11, 2024. He serves as Non-Executive Director at Kanabo Group Plc since May 04, 2023.He se...

Leadership Team

NamePositionTenureCompensationOwnership
Sharon Malka
MD, CEO & Executive Director1.7yrsUS$556.60k0.11%
A$ 46.7k
Michael Shtein
Co-Founder & CTO9.3yrsUS$213.06k1.5%
A$ 627.3k
Liat Bar Ziv Alperovitz
Chief Financial Officer1.7yrsUS$231.52kno data
James Tour
Co-Founder & Scientific Advisorno datano datano data
Shirley Shoshaney-Kleiner
C.M.O.no datano datano data
Davidi Tulipman
Chief Product Officer2.3yrsno datano data
Yair Poplawski
Chief Business Officer1.8yrsno datano data
Daniel Vorenberg
Head of Engineeringless than a yearno datano data
Andrew Ritter
Company Secretary1.1yrsno datano data

1.7yrs

Average Tenure

Experienced Management: DTZ's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Sharon Malka
MD, CEO & Executive Directorless than a yearUS$556.60k0.11%
A$ 46.7k
Glenn Kelly
Non-Executive Directorless than a yearUS$10.00kno data
Bernard Brookes
Independent Non-Executive Chairman4.8yrsUS$141.53k0.62%
A$ 257.2k
Doron Eldar
Non-Executive Director4.8yrsUS$98.47k0.37%
A$ 153.3k
Kerry Harpaz
Non-Executive Director3.2yrsUS$79.73k0%
A$ 0
Mitchell Board
Non-Executive Directorless than a yearUS$13.13k0.0055%
A$ 2.3k

2.1yrs

Average Tenure

Experienced Board: DTZ's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.